| ANOVA | Analysis of variance |
| BBB | Blood–brain barrier |
| BrdU | Bromodeoxyuridine |
| CCA | Common carotid artery |
| CCL2 | C–C motif chemokine ligand 2 |
| CCL2-MSC | Mannitol+CCL2-overexpressing hUC-MSC-treatment group |
| CCR2 | C–C motif chemokine receptor 2 |
| DCX | Doublecortin |
| ECA | External carotid artery |
| GFAP | Glial fibrillary acidic protein |
| GFP | Green fluorescent protein |
| hUC-MSC | Human umbilical cord-derived mesenchymal stem cell |
| Iba-1 | Ionized calcium-binding adapter molecule 1 |
| IV | Intravenous |
| MAN | Mmannitol-treatment group |
| M-MSC | Mannitol + hUC-MSC-treatment group |
| MSC | Mesenchymal stem cell |
| MCAo | Middle cerebral artery occlusion |
| MEM | Minimum essential medium |
| mNSS | Modified neurological severity score |
| NeuN | Neuronal nuclei |
| PBS | Phosphate-buffered saline |
| PFA | Paraformaldehyde |
| r-tPA | Recombinant tissue plasminogen activator |
| RECA-1 | Rat endothelial cell antigen 1 |
| RT-PCR | Reverse transcription polymerase chain reaction |
| SEM | Standard error of the mean |
| TTC | 2:3:5-triphenyltetrazolium chloride |
| VEGF | Vascular endothelial growth factor |